SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Miragen Therapeutics Q1 EPS $(0.180) Beats $(0.190) Estimate, Sales $800.000K Beat $580.000K Estimate

Miragen Therapeutics (NASDAQ:MGEN) reported quarterly losses of $(0.180) per share which beat the analyst consensus estimate of $(0.190) by 5.26 percent. This is a 52.63 percent increase over losses of $(0.380) per share

Benzinga · 05/07/2020 20:28

Miragen Therapeutics (NASDAQ:MGEN) reported quarterly losses of $(0.180) per share which beat the analyst consensus estimate of $(0.190) by 5.26 percent. This is a 52.63 percent increase over losses of $(0.380) per share from the same period last year. The company reported quarterly sales of $800.000 thousand which beat the analyst consensus estimate of $580.000 thousand by 37.93 percent. This is a 115.05 percent increase over sales of $372.000 thousand the same period last year.